Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Exercise promotes a cardioprotective gene program in resident cardiac fibroblasts
Janet K. Lighthouse, … , Alex Rosenberg, Eric M. Small
Janet K. Lighthouse, … , Alex Rosenberg, Eric M. Small
Published January 10, 2019
Citation Information: JCI Insight. 2019;4(1):e92098. https://doi.org/10.1172/jci.insight.92098.
View: Text | PDF
Research Article Cardiology Cell biology

Exercise promotes a cardioprotective gene program in resident cardiac fibroblasts

  • Text
  • PDF
Abstract

Exercise and heart disease both induce cardiac remodeling, but only disease causes fibrosis and compromises heart function. The cardioprotective benefits of exercise have been attributed to changes in cardiomyocyte physiology, but the impact of exercise on cardiac fibroblasts (CFs) is unknown. Here, RNA-sequencing reveals rapid divergence of CF transcriptional programs during exercise and disease. Among the differentially expressed programs, NRF2-dependent antioxidant genes — including metallothioneins (Mt1 and Mt2) — are induced in CFs during exercise and suppressed by TGF-β/p38 signaling in disease. In vivo, mice lacking Mt1/2 exhibit signs of cardiac dysfunction in exercise, including cardiac fibrosis, vascular rarefaction, and functional decline. Mechanistically, exogenous MTs derived from fibroblasts are taken up by cultured cardiomyocytes, reducing oxidative damage–dependent cell death. Importantly, suppression of MT expression is conserved in human heart failure. Taken together, this study defines the acute transcriptional response of CFs to exercise and disease and reveals a cardioprotective mechanism that is lost in disease.

Authors

Janet K. Lighthouse, Ryan M. Burke, Lissette S. Velasquez, Ronald A. Dirkx Jr., Alessandro Aiezza II, Christine S. Moravec, Jeffrey D. Alexis, Alex Rosenberg, Eric M. Small

×

Figure 8

MT1/2 deficiency leads to exercise intolerance and cardiac dysfunction.

Options: View larger image (or click on image) Download as PowerPoint
MT1/2 deficiency leads to exercise intolerance and cardiac dysfunction.
...
MT1/2KO (KO) mice or 129SvJ WT controls were subjected to a 28 day swimming regimen. (A) Heart weight/tibia length (HW/TL) ratio of KO and WT animals reveals cardiac hypertrophy after 28-day swim but no significant difference due to loss of MT1/2. Echocardiographic determination of (B) ejection fraction, (C) fractional shortening, and (D) systolic volume indicates that systolic cardiac function is impaired in swim-trained KO mice. (E) Representative polarized light images of Picrosirius red staining of left ventricular free wall (LVFW) to evaluate fibrosis in swim-trained WT and KO animals. WT sedentary, n = 8; WT swim, n = 11; KO sedentary, n = 3; KO swim, n = 10. (F–H) Quantification of Picrosirius red staining from similar regions of the LVFW demonstrates increased fibrosis in the (F) interstitial, (G) epicardial, and (H) perivascular regions of KO animals. Pixel coverage was quantified to indicate area of fibrosis. WT swim, n = 3; KO swim, n = 5. (I) Isolectin and von Willebrand Factor costaining of LVFW to evaluate vascularization in swim-trained WT and KO animals. Three to 5 regions of interest were quantified per animal. WT swim, n = 3; KO swim, n = 5. (J) Pixel density quantification reveals reduced vascularization in KO animals compared with controls. (K) Echocardiographic analysis of E/A ratio demonstrates impaired diastolic function in swim-trained WT and KO mice, n = 4. Statistics in F–H and K were performed using two-tailed Student’s t test. Statistics in B–D were performed using 2-way ANOVA and Tukey’s post-hoc test. Statistics in A were performed using 1-way ANOVA and Tukey’s post-hoc test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Scale bars: 50 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts